← All companies

VCRE

Vicore Pharma Holding AB (publ)

VCRE Nasdaq Pharmaceutical Preparations EDGAR ↗

$11.53

+0.16 +1.41%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$10.50 – $17.80

Recent SEC filings

6 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 6, 2026

Other filings

SEC STAFF ACTION Jun 30, 2026 CERT Jun 30, 2026 20FR12B/A Jun 9, 2026 20FR12B May 22, 2026 DRS Apr 17, 2026